COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,778 Articles (22,946 medRxiv, 8,832 bioRxiv)

Most recent first Previous |  Page 1193: Articles 11921-11930  | Next

Patient trajectories among hospitalised COVID-19 patients vaccinated with an mRNA vaccine in Norway: a register-based cohort study
Whittaker, R., Brathen Kristofferson, A., Valcarcel Salamanca, B., Seppala, E., Golestani, K., Kvale, R., Watle, S., Buanes, E.
10.1101/2021.11.05.21265958 — Posted: 2021-11-09 Discussion: Onsite
Safety Assessment of BNT162b2 Vaccine in Adolescents Aged 12-15 Years
Patel, J., Bhavsar, B., Parikh, S., Ladani, N.
10.1101/2021.11.06.21266016 — Posted: 2021-11-09
Compassionate Use of REGEN-COV(R) in Patients with COVID-19 and Immunodeficiency-Associated Antibody Disorders
Stein, D., Oviedo-Orta, E., Kampman, W. A., McGinniss, J., Betts, G., McDermott, M., Holly, B., Lancaster, J. M., Braunstein, N., Yancopoulos, G. D., Weinreich, D. M.
10.1101/2021.11.05.21265911 — Posted: 2021-11-09
De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case report
Gandhi, S., Klein, J., Robertson, A., Pena-Hernandez, M. A., Lin, M. J., Roychoudhury, P., Lu, P., Fournier, J., Ferguson, D., Mohamed Bakhash, S. A., Muenker, M. C., Srivathsan, A., Wunder, E. A., Kerantzas, N., Wang, W., Pyle, A., Wilen, C. B., Ogbuagu, O., Greninger, A. L., Iwasaki, A., Schulz, W. L., Ko, A. I.
10.1101/2021.11.08.21266069 — Posted: 2021-11-09 Discussion: Onsite
SARS-CoV-2 testing and COVID-19 related primary care use among people with citizenship, permanent residency, and temporary immigration status in British Columbia: Cross-sectional analysis of population-based administrative data
Wiedmeyer, M.-l., Goldenberg, S., Peterson, S., Wanigaratne, S., Machado, S., Tayyar, E., Braschel, M., Carrillo, R., Sierra-Heredia, C., Tuyisenge, G., Lavergne, M. R.
10.1101/2021.11.05.21265978 — Posted: 2021-11-09
Parents intention to vaccinate their 5-11 years old children with the COVID-19: vaccine rates, predictors and the role of incentives
Shmueli, L.
10.1101/2021.11.05.21265900 — Posted: 2021-11-09
Forecasting the COVID-19 Pandemic: Lessons learned and future directions
Sundar, S., Schwab, P., Tan, J. Z. H., Romero-Brufau, S., Celi, L. A., Wangmo, D., Della Penna, N.
10.1101/2021.11.06.21266007 — Posted: 2021-11-09
Internet-based health survey on loneliness and sleep-related problems among the working-age population in Japan during COVID-19
Tesen, H., Konno, Y., Tateishi, S., Hino, A., Tsuji, M., Ogami, A., Nagata, M., Muramatsu, K., Yoshimura, R., Fujino, Y.
10.1101/2021.11.07.21266001 — Posted: 2021-11-09
Refining reproduction number estimates to account for unobserved generations of infection in emerging epidemics
Brizzi, A., O'Driscoll, M., Dorigatti, I.
10.1101/2021.11.08.21266033 — Posted: 2021-11-09
Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of breakthrough infections: analysis of the Virus Watch community cohort.
Aldridge, R. W., Yavlinsky, A., Nguyen, V. G., Eyre, M. T., Shrotri, M., Navaratnam, A. M. D., Beale, S., Braithwaite, I., Byrne, T. E., Kovar, J., Fragaszy, E., Fong, E. W. L., Geismar, C. R., Patel, P., Rodger, A., Johnson, A. M., Hayward, A. C.
10.1101/2021.11.05.21265968 — Posted: 2021-11-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).